Skip to main content
SpringerLink
Log in

Nutzen und Grenzen von Mutagenitäts- und Kanzerogenitätsstudien

  • Conference paper
Book cover Phytopharmaka III

Zusammenfassung

Maligne Erkrankungen stellen derzeit nach Herz-Kreislauf-Erkrankungen die zweithäufigste Todesursache in den Industrieländern dar und machen etwa 20%–25% aller Todesfälle aus. Etwa 1 Million neue Krebserkrankungen werden jährlich in den USA diagnostiziert, die Anzahl krebsbedingter Todesfälle pro Jahr beträgt etwa eine halbe Million [66]. Die Tumor- inzidenz bzw. -mortalität in den EU-Ländern ist ähnlich: In den 12 Ländern der Europäischen Union mit einer gesamten Population von etwa 327 x 106 werden jährlich 1,2 Millionen Neuerkrankungen sowie etwa 800.000 krebsbedingte Todesfälle gezählt [8, 34, 36].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abel G, Schimmer O (1983) Induction of structural chromosome aberrations and sister chromatid exchanges in human lymphocytes in vitro by aristolochic acid. Human Gen 64: 131–133

    Article  CAS  Google Scholar 

  2. Batsford S, Kluthe R, Vogt A (1982) Double blind study on the influence of aristolochic acid on granulocyte phagocytic acitivty. Arzneimittelforschung 32: 443–445

    PubMed  Google Scholar 

  3. Bertram B (1989) Flavonoide. Eine Klasse von Pflanzeninhaltstoffen mit vielfältigen biologischen Wirkungen, auch mit carcinogener Wirkung?. Dtsch Apoth Ztg 129: 2561–2571

    CAS  Google Scholar 

  4. Brown JP, Dietrich PS (1979) Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test. Activation of flavonol glycosides by mixed glycosidase from rat cecal bacteria and other sources. Mutat Res 66: 223–240

    Article  PubMed  CAS  Google Scholar 

  5. Brown JP, Dietrich PS, Brown RJ (1977) Frameshift mutagenicity of certain naturally occuring phenolic compounds in the Salmonella/microsome test. Activation of anthraquinone and flavonol glycosides by gut bacterial enzymes. Biochem Soc Trans 5: 1489–1492

    PubMed  CAS  Google Scholar 

  6. Brown JP (1980) A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res 75: 243–277

    PubMed  CAS  Google Scholar 

  7. Bundesgesundheitsamt (1982): Deutsche Apotheker Zeitung 122: 2287

    Google Scholar 

  8. Cancer in the European Community. Eur Cancer News 5(1992): 1–7

    Google Scholar 

  9. Carins J (1986) Das Krebsproblem. In: Schirrmacher V (Hrsg) Krebs-Tumoren, Zellen, Gene. Spektrum der Wissenschaften, Heidelberg S10–21

    Google Scholar 

  10. Carver JH, Carrano AV, MacGregor JT (1983) Genetic effects of the flavonols quercetin, kaempferol, and galangin on Chinese hamster ovary cells in vitro. Mutat Res 113: 45–60

    PubMed  CAS  Google Scholar 

  11. Crebelli R, Auilina G, Falcone E, Careere A (1987) Urinary and fecal mutagenicity in Sprague-Dawley rats dosed with the food mutagens quercetin and rutin. Food Chem Toxicol 25, 9–15

    Article  PubMed  CAS  Google Scholar 

  12. Frei H, Würgler FE, Juon H, Hall CB, Graf U (1985) Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests. Arch Toxicol 56: 158–166

    Article  PubMed  CAS  Google Scholar 

  13. Gaspar J, Rodrigues A, Laires A, Silva F, Costa S, Monteiro MJ, Monteiro C, Rueff J (1994) On the mechanisms of genotoxicity and metabolism of quercetin. Mutagenesis 9: 445–449

    Article  PubMed  CAS  Google Scholar 

  14. Götzl E, Schimmer O (1993) Mutagenicity of aristolochic acids (I, II) and aristolochic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarens. Mutagenesis 8: 17–22

    Article  PubMed  Google Scholar 

  15. Hang BQ, Wu Y, Hang S, Yang Y, Wang MS (1985) Effect of quercetin and rutin on the occurence of micronuclei in mouse bone-marrow polychromatic erythrocytes. J Nanjing Coll Pharm 16: 52–55

    CAS  Google Scholar 

  16. Hankey BF (1992) Trends in U.S. Cancer Mortality by Age Group, 1973-1989. J Natl Cancer Inst 84: 1391

    Article  Google Scholar 

  17. Herrmann K (1988) On the occurrence of flavonol and flavone glycoside in vegetables. Z Lebensm Unters Forsch 186: 1–5

    Article  CAS  Google Scholar 

  18. Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40: 2379–2383

    Article  CAS  Google Scholar 

  19. Hirono I (1992) Is quercetin carcinogenic? Jpn J Cancer Res 83: 313–314

    PubMed  CAS  Google Scholar 

  20. Hirono I, Ueno I, Hosaka S, Takanashi H, Matsushima T, Sugimura T, Natori S (1981) Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett 13: 15–21

    Article  PubMed  CAS  Google Scholar 

  21. Hosaka S, Hirono I (1981) Carcinogenicity test of quercetin by pulmonary adenoma bioassay in strain A mice. Gann 72: 327–328

    PubMed  CAS  Google Scholar 

  22. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, Conney AH (1983) Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant fla-vonoids. Carcinogenesis 4: 1631–1637

    Article  PubMed  CAS  Google Scholar 

  23. Ishikawa M, Oikawa T, Hosokawa M, Hamada J, Morikawa K, Kobayashi H (1985) Enhancing effect of quercetin on 3-methylcholanthrene carcinogenesis in C57B1/6 mice. Neoplasma 32: 435–441

    PubMed  CAS  Google Scholar 

  24. Ito N, Hagiwara A, Tamano S, Kagawa M, Shibata M, Kurata Y, Fukushima S (1989) Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn J Cancer Res 80: 317–325

    Article  PubMed  CAS  Google Scholar 

  25. Ito N (1992) Is quercetin carcinogenic? Jpn J Cancer Res 83: 312–313

    Article  PubMed  CAS  Google Scholar 

  26. Kato R, Nakadate T, Yamamoto S, Sugimura T (1983) Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4: 1301–1305

    Article  PubMed  CAS  Google Scholar 

  27. Komatsu N, Nawata H, Kimino T, Ahoji J, Tada A (1973) Biological activities of aristolochic acid. II. Effect on experimental tumor, bacterial infection and RES (reticuloendothelial system) function. Showa Igakkai Zasshi 33: 776–782

    CAS  Google Scholar 

  28. Maier P, Schawalder HP, Weibel B, Zbinden G (1985) Aristolochic acid induces 6-thioguanineresistant mutants in an extra hepatic tissue in rats after oral application. Mutat Res 108: 143–148

    Article  Google Scholar 

  29. Marks F, Schwarz M, Förstenberger G (1995) Promotion and Carcinogenesis. In: Arcos JC (ed) Chemical Induction of Cancer. Birkhäuser, Boston, pp 123–184

    Chapter  Google Scholar 

  30. Meltz ML, MacGregor JT (1981) Activity of the plant flavonol quercetin in the mouse lymphoma L 5178y TK+/-mutation, DNA single-strand break and Balb/c3T3 chemical transformation assays. Mutat Res 88: 317–324

    Article  PubMed  CAS  Google Scholar 

  31. Mengs U (1983) On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 52: 209–220

    Article  PubMed  CAS  Google Scholar 

  32. Mengs U, Lang W, Poch JA (1982) The carcinogenic action of aristolochic acid in rats. Arch Toxicol 51: 107–119

    Article  CAS  Google Scholar 

  33. Möse JR (1975) The effect of aristolochic acid on the development of methylcholanthrene tumors in mice. Oesterr Z Onkol 2: 151–153

    Google Scholar 

  34. Moller JO, Esteve J, Moller H, Renard H (1990) Cancer in the European Community and its member states. Eur J Cancer 26(11/12)

    Google Scholar 

  35. Morino K, Matsukura N, Kawachi T, Ohgaki H, Sugimura T, Hirono I (1982) Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis 3: 93–97

    Article  PubMed  CAS  Google Scholar 

  36. Muir CS, Boyle P (1990) The burden of cancer in Europe. Eur J Cancer 26: 1111–1113

    Article  PubMed  CAS  Google Scholar 

  37. National Toxicology Program, Research Triangle Park, NC, 27709, USA (1991) NTP technical report on the toxicology and carcinogenesis studies of quercetin in F344/N rats. Natl Toxicol Program Tech Rep Ser 409

    Google Scholar 

  38. Ngomuo AJ, Jones RS (1996) Genotoxicity studies of quercetin and shikimate in vivo in the bone marrow of mice and gastric mucosal cells of rats. Vet Hum Toxicol 38: 176–180

    PubMed  CAS  Google Scholar 

  39. Nishino H, Nishino A, Iwashima A, Tanaka K, Matsuura T (1984) Quercetin inhibits the action of 12-O-tetradecanoylphorbol 13-acetate, a tumor promotor. Oncology 41: 120–123

    Article  PubMed  CAS  Google Scholar 

  40. Ogawa S, Hirayama T, Nohara M, Tokuda M, Hirai K, Fukui S (1985) The effect of quercetin on the mutagenicity of 2-acetylaminofluorene and benzo[a]pyrene in Salmonella typhimurium strains. Mutat Res 142: 103–107

    Article  PubMed  CAS  Google Scholar 

  41. Ogawa S, Hirayama T, Tokuda M, Hirai K, Fukui S (1986) The effect of quercetin, a mutagenicity-enhan-cing agent, on the metabolism of 2-acetylaminofluorene with mammalian metabolic activation systems. Mutat Res 162: 179–186

    Article  PubMed  CAS  Google Scholar 

  42. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT (1980) Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res 40: 3468–3472

    PubMed  CAS  Google Scholar 

  43. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitake LM, Kelloff GJ et al (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethaneinduced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17: 1305–1311

    Article  PubMed  CAS  Google Scholar 

  44. Pfau W, Pool-Zobel BL, von der Lieth CW, Wiessler M (1990) The structural basis for the mutagenicity of aristolochic acid. Cancer Lett 55: 7–11

    Article  PubMed  CAS  Google Scholar 

  45. Pfau W, Schmeiser HH, Wiessler M (1991) N6-Adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. Chem Res Toxicol 4: 581–586

    Article  PubMed  CAS  Google Scholar 

  46. Robisch G, Schimmer O, Goeggelmann W (1982) Aristolochic acid is a direct mutagen in Salmonella typhimurium. Mutat Res 105: 201–204

    Article  PubMed  CAS  Google Scholar 

  47. Sahu RK, Basu R, Sharma A (1981) Genetic toxicological testing of some plant flavonoids by the micronucleus test. Mutat Res 89: 69–74

    Article  PubMed  CAS  Google Scholar 

  48. Sahu SC, Gray GC (1996) Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-trans-ferase in isolated rat liver nuclei. Cancer Lett 104: 193–196

    Article  PubMed  CAS  Google Scholar 

  49. Saito D, Shirai A, Matsushima T, Sugimura T, Hirono I (1980) Test of carcinogenicity of quercetin, a widely distributed mutagen in food. Teratog Carcinog Mutagen 1: 213–221

    Article  PubMed  CAS  Google Scholar 

  50. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 56: 2025–2028

    PubMed  CAS  Google Scholar 

  51. Schmeiser HH, Pool BL, Wiessler M (1984) Mutagenicity of the two components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. Cancer Lett 23: 97–101

    Article  PubMed  CAS  Google Scholar 

  52. Schmeiser HH, Schoepe KB, Wiessler M (1988) DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9: 297–303

    Article  PubMed  CAS  Google Scholar 

  53. Schmeiser HH, Wiessler M (1995) Carcinogene Naturstoffe. Bioforum 18: 306–311

    CAS  Google Scholar 

  54. Stoewsand GS, Anderson JL, Boyd JN, Hrazdina G, Babish JG, Walsh KM, Losco P (1984) Quercetin: a mutagen, not a carcinogen, in Fisher rats. J Toxicol Environ Health 14: 105–114

    Article  PubMed  CAS  Google Scholar 

  55. Shunack W, Mutschier E, Rochelmeyer H (1967) Influence of aristolochic acids I and II on the survival rate of mice infected with pneumococci. Arzneimittelforschung 17: 1215–1218

    Google Scholar 

  56. Taj S, Nagarajan B (1996) Inhibition by quercetin and luteolin of chromosomal alterations induced by salted, deep-fried fish and mutton in rats. Mutat Res 369: 97–106

    Article  PubMed  CAS  Google Scholar 

  57. Takanashi H, Aiso S, Hirono I, Matsushima T, Sugimura T (1983) Carcinogenicity test of quercetin and kaempferol in rats by oral administration. J Food Safety 5: 55–60

    Article  CAS  Google Scholar 

  58. Umezawa K, Matsushima T, Sugimura T, Hirakawa T, Tanaka M, Katoh Y, Takayama S (1977) In vitro transformation of hamster embryo cells by quercetin. Toxicol Lett 1: 175–178

    Article  CAS  Google Scholar 

  59. Van Duuren BL, Goldschmidt BM (1976) Carcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Cancer Inst 56: 1237–1242

    PubMed  Google Scholar 

  60. Van der Hoeven JCM, Bruggeman IM, Debets FMH (1984) Genotoxicity of quercetin in cultured mammalian cells. Mutat Res 136: 9–21

    Article  PubMed  Google Scholar 

  61. Vanherweghem JL, Depierreux M, Tielemens C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vander-welde D, Verbeelen D, Vanhaelen-Fastre R, Vanhaelen M (1993) Rapidly progressive interstitial renal fibrosis in young women: association with a slimming regimen including Chinese herbs. Lancet 341: 387–391

    Article  PubMed  CAS  Google Scholar 

  62. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL (1994) Identification of aristolochic acid in Chinese herbs. Lancet 343: 174

    Google Scholar 

  63. Wagner H, Porksch A, Vollmer A, Kreutzkamp B, Bauer J (1985) In vitro phagocytosis stimulation by isolated plant materials measured in the phagocytosis-chemoluminescence (CL) model. Plant Med 51: 139–144

    Article  Google Scholar 

  64. Wang CY, Pamukcu AM, Bryan GT (1976) Bracken fern, a naturally occurring carcinogen. In: Stock CC, Santamaria L, Mariani P, Gorin S (eds) Ecological Perspectives on Carcinogens and Cancer Control (Medicine, Biology, Environment), Harger, Basel, pp 565–572

    Google Scholar 

  65. Watson WAF (1982) The mutagenic activity of quercetin and kaempferol in Drosophila melanogaster. Mutat Res 103: 145–147

    Article  PubMed  CAS  Google Scholar 

  66. Weinstein IB (1991) Cancer prevention: recent progress and future opportunities. Cancer Res (Suppl) 51:5080s-5080s

    Google Scholar 

  67. Yoshida MA, Sasaki M, Sugimura K, Kawachi T (1980) Cytogenetic effects of quercetin on cultured mammalian cells. Proc Jpn Acad [B] 56: 443–447

    Article  CAS  Google Scholar 

  68. Zhu BT, Ezell EL, Liehr JG (1994) Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 269: 292–299

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fachrichtung Lebensmittelchemie und Umwelttoxikologie, Fachbereich Chemie, Universität Kaiserslautern, Erwin-Schrödinger-Straße, D-67663, Kaiserslautern, Deutschland

    Prof. Dr. G. Eisenbrand & Prof. Dr. W. Tang

Authors
  1. Prof. Dr. G. Eisenbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. W. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Klinische Pharmakologie, Klinikum der Johann Wolfgang Goethe-Universität, Haus 74 Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    Dieter Loew  & Norbert Rietbrock  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Eisenbrand, G., Tang, W. (1997). Nutzen und Grenzen von Mutagenitäts- und Kanzerogenitätsstudien. In: Loew, D., Rietbrock, N. (eds) Phytopharmaka III. Steinkopff. https://doi.org/10.1007/978-3-642-95993-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-95993-6_1

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-95994-3

  • Online ISBN: 978-3-642-95993-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation